Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

NCT00653250 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: celecoxib
PROCEDURE: biopsy
PROCEDURE: therapeutic conventional surgery

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]